Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 2146 to 2160 of 9026 results

  1. Donidalorsen for preventing recurrent attacks of hereditary angioedema in people 12 years and over [ID6457]: draft guidance

    We are listening to your views on this Technology appraisal guidance. Comments close 21 May 2026.

    Technology appraisal guidance
    In consultation

  2. Prostate cancer: diagnosis and management (update): scoping

    We are listening to your views on this NICE guideline. Comments close 27 May 2026.

    NICE guideline
    In consultation

  3. Lecanemab for treating mild cognitive impairment or mild dementia caused by Alzheimer's disease [ID4043]

    In development Reference number: GID-TA11220 Expected publication date: TBC

    Technology appraisal guidance
    In development

  4. Donanemab for treating mild cognitive impairment or mild dementia caused by Alzheimer's disease [ID6222]

    In development Reference number: GID-TA11221 Expected publication date: TBC

    Technology appraisal guidance
    In development

  5. Donidalorsen for preventing recurrent attacks of hereditary angioedema in people 12 years and over [ID6457]

    In development Reference number: GID-TA11576 Expected publication date:  18 June 2026

    Technology appraisal guidance
    In development

  6. Cancer case finding technologies to support early recognition of suspected cancer symptoms in primary care: early use assessment

    In development Reference number: GID-HTG10176 Expected publication date: TBC

    HealthTech guidance
    In development

  7. Prostate cancer: diagnosis and management (update)

    In development Reference number: GID-NG10451 Expected publication date:  17 December 2027

    NICE guideline
    In development

  8. Sleep disordered breathing

    Awaiting development Reference number: GID-QS10096 Expected publication date: TBC

    Quality standard
    Awaiting development

  9. Digital platforms to support rehabilitation before and after primary elective hip or knee replacement surgery

    In development Reference number: GID-HTE10069 Expected publication date: TBC

    Health technology evaluations
    In development

  10. Ectopic pregnancy and miscarriage

    In development Reference number: GID-QS10202 Expected publication date:  17 June 2026

    Quality standard
    In development

  11. Aficamten for treating symptomatic obstructive hypertrophic cardiomyopathy [ID6575]

    In development Reference number: GID-TA11742 Expected publication date:  29 July 2026

    Technology appraisal guidance
    In development

  12. Histamine dihydrochloride with interleukin-2 for maintenance treatment of acute myeloid leukaemia [ID1627]

    In development Reference number: GID-TA10575 Expected publication date:  05 August 2026

    Technology appraisal guidance
    In development

  13. Histamine dihydrochloride with interleukin-2 for maintenance treatment of acute myeloid leukaemia [ID1627]: draft guidance

    We are listening to your views on this Technology appraisal guidance. Comments close 22 May 2026.

    Technology appraisal guidance
    In consultation

  14. Durvalumab with tremelimumab and transarterial chemoembolisation with or without lenvatinib for treating locally advanced hepatocellular carcinoma [ID6527]

    Awaiting development Reference number: GID-TA11653 Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  15. COLOFIT algorithm to guide colorectal cancer pathway referral in primary care

    Awaiting development Reference number: GID-HTG10850 Expected publication date: TBC

    HealthTech guidance
    Awaiting development